Ullern H, Johannessen JA, Kasikci F, Formica M, Karimi Melve N, Andresen S, Brech A, Axcrona K, Jørgensen K, Farkas L, Enserink JM, Knævelsrud H (2026)
FLCN loss is characterized by SQSTM1/p62 accumulation despite functional autophagy flux in Birt-Hogg-Dubé syndrome-associated kidney cancer
Autophagy Rep, 5 (1), 2705631
DOI 10.1080/27694127.2026.2705631, PubMed 42569319

Willoch-Allen K, Zhao Z, Ayuda-Durán P, Mikaeloff F, Struyf N, Österroos A, Lehmann S, Kallioniemi O, Saarela J, Tyner JW, Erkers T, Enserink JM, Aittokallio T (2026)
A multi-center study on the consistency of drug sensitivity testing in patients with acute myeloid leukemia
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01480-4, PubMed 42135420

Ayuda-Durán P, Hanes R, Rønneberg L, Alver TN, Øy GF, Hauge S, Andersen AN, Egeland EV, Juell S, Nakken S, Asenso TQ, Zucknick M, Syljuåsen RG, Mælandsmo GM, Hovig E, Enserink JM (2026)
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential
Commun Med (Lond), 6 (1)
DOI 10.1038/s43856-026-01583-w, PubMed 42062484